DEPOSIT AGREEMENTDeposit Agreement • June 1st, 2020 • Calliditas Therapeutics AB • Pharmaceutical preparations • Delaware
DEPOSIT AGREEMENT, dated as of ___________, 2020, by and among (i) Calliditas Therapeutics AB, a company organized under the laws of the Kingdom of Sweden, and its successors (the “Company”), (ii) CITIBANK, N.A., a national banking association organized under the laws of the United States of America (“Citibank”) acting in its capacity as depositary, and any successor depositary hereunder (Citibank in such capacity, the “Depositary”), and (iii) all Holders and Beneficial Owners of American Depositary Shares issued hereunder (all such capitalized terms as hereinafter defined).
●] Common Shares (Quota Value SEK 0.04 Per Share) (including [●] American Depositary Shares, each Representing Two Common Shares) Underwriting AgreementUnderwriting Agreement • June 1st, 2020 • Calliditas Therapeutics AB • Pharmaceutical preparations • New York
This letter is being delivered to you in connection with the offering by Calliditas Therapeutics AB (the “Company”) of (i) common shares, quota value SEK 0.04 per share (the “Common Shares”), and (ii) Common Shares to be delivered in the form of American Depositary Shares (“ADSs”), of the Company, and the lock-up letter dated ______, 20__ (the “Lock-up Letter”), executed by you in connection with such offering, and your request for a [waiver] [release] dated [insert date], 20__, with respect to [__ Common Shares (the “Lock-Up Shares”)] [__ ADSs (the “Lock-Up ADSs”)].
